NEW YORK (January 15, 2013) — Health care providers and hospitals are being offered up to $27 billion in federal financial incentives to use electronic health records (EHRs) in ways that demonstrably improve the quality of care. The incentives are based, in part, on the ability to electronically report clinical quality measures. By 2014, providers nationwide will be expected to document and report care electronically, and by 2015, they will face financial penalties if they don’t meaningfully use EHRs.
A new, federally-funded study by Weill Cornell Medical College in the Jan. 15 issue of Annals of Internal Medicine demonstrates ways in which quality measurement from EHRs — which are primarily designed for documentation of clinical care for individual patients — can be improved. In a large cross-sectional study in New York state, researchers demonstrated that the accuracy of quality measures can vary widely. Electronic reporting, although generally accurate, can both underestimate and overestimate quality.
“This study reveals how challenging it is to measure quality in an electronic era. Many measures are accurate, but some need refinement,” says the study’s senior author, Dr. Rainu Kaushal, director of the Center for Healthcare Informatics Policy, chief of the Division of Quality and Medical Informatics and the Frances and John L. Loeb Professor of Medical Informatics at Weill Cornell.
“Getting electronic quality measurement right is critically important to ensure that we are accurately measuring and incentivizing high performance by physicians so that we ultimately deliver the highest possible quality of care. Many efforts to do this are underway across the country,” continues Dr. Kaushal, also a professor of pediatrics, medicine, and public health at Weill Cornell and a pediatrician at the Komansky Center for Children’s Health at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
For this study, Weill Cornell researchers analyzed clinical data from the EHRs of one of the largest community health center networks in New York state. The research team examined the accuracy of electronic reporting for 12 quality measures, 11 of which are included in the federal government’s set of measures for incentives. What they found was fairly good consistency for nine measures, but not for the other three.
“The variation in quality measurement that we found in a leading electronic health record system speaks to the need to test and iteratively refine traditional quality measures so that they are suited to the documentation patterns in EHRs,” says the study’s lead investigator, Dr. Lisa Kern, a general internist and associate director for research at the Center for Healthcare Informatics at Weill Cornell.
The automated reports generally performed well. However, they underestimated the percentage of patients receiving prescriptions for asthma and receiving vaccinations to protect from bacterial pneumonia. A third measure suggested that more patients with diabetes had cholesterol under control than actually did. The automated report said 57 percent of eligible diabetic patients had cholesterol controlled, while a manual check of the charts showed it was actually only 37 percent. Part of the problem is that physicians and nurses filling out the EHRs may be typing in information in a place that is not being captured by quality reporting algorithms.
“EHRs create the opportunity to measure and provide feedback to clinicians regarding quality performance in real time, thereby improving clinical practice,” says Dr. Kern, who is also an associate professor of public health and medicine at Weill Cornell.
Dr. Kaushal adds, “EHRs are not just electronic versions of paper records but rather tools that enable transformation in the way care is delivered, documented, measured and improved. The federal meaningful use program will enable the deployment of these promising systems across the country, thereby enabling health care to enter the digital age.”
This study was funded by the federal Agency for Healthcare Research and Quality and featured in an AHRQ exemplary video, entitled “Developing and Testing Quality Measures for Interoperable Electronic Health Records.” To view the video, visit: http://healthit.ahrq.gov/EQMKaushalVideo.
Weill Cornell Medical College
Weill Cornell Medical College, Cornell University’s medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, the Medical College is the first in the U.S. to offer its M.D. degree overseas. Weill Cornell is the birthplace of many medical advances — including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson’s disease, and most recently, the world’s first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with the Methodist Hospital in Houston. For more information, visit weill.cornell.edu.